The trading price of ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) closed lower on Friday, June 13, and closing at $0.70, -3.89% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.7 and $0.8. In examining the 52-week price action we see that the stock hit a 52-week high of $1.08 and a 52-week low of $0.27. Over the past month, the stock has gained 41.15% in value.
ImmunoPrecise Antibodies Ltd, whose market valuation is $32.10 million at the time of this writing, is expected to release its quarterly earnings report on 2025-Mar-27. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest IPA has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that IPA’s price is currently 20.09% off the SMA20 and 41.26% off the SMA50. The RSI metric on the 14-day chart is currently showing 65.69, and weekly volatility stands at 12.53%. When measured over the past 30 days, the indicator reaches 7.48%. ImmunoPrecise Antibodies Ltd (NASDAQ:IPA)’s beta value is currently sitting at 0.24, while the Average True Range indicator is currently displaying 0.09.
To see how ImmunoPrecise Antibodies Ltd stock has been performing in comparison to its peers in the industry, here are the numbers: IPA stock’s performance was -3.89% in the latest trading, and -31.89% in the past year.
An evaluation of the daily trading volume of ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) indicates that the 3-month average is 2.11 million. However, this figure has increased over the past 10 days to an average of 8.13.
Currently, records show that 45.77 million of the company’s shares remain outstanding. The insiders hold 13.30% of outstanding shares, whereas institutions hold 8.65%. The stats also highlight that short interest as of 2025-05-30, stood at 0.25 million shares, resulting in a short ratio of 0.86 at that time. From this, we can conclude that short interest is 55.00 of the company’s total outstanding shares. It is noteworthy that short shares in May were down slightly from the previous month’s figure, which was 0.31 million. However, since the stock’s price has seen 70.39% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
